Investment Thesis
Elite Health Systems is a distressed company with zero revenue generation, persistent operating losses of $2M, and deteriorating cash position despite holding $4M in cash reserves. The company is burning cash at an unsustainable rate with negative free cash flow of $1.4M and negative ROE/ROA metrics, indicating fundamental operational failure in a specialty outpatient healthcare services business.
Strengths
- Strong liquidity position with $4M cash and 15.83x current ratio
- Low absolute liabilities at $291K relative to assets
- Positive stockholders equity of $5M provides technical solvency cushion
Risks
- Complete revenue collapse to $0 indicates loss of all business operations or reporting failure
- Sustained negative operating cash flow of $1.4M depleting cash reserves rapidly at current burn rate
- Negative returns on equity (-40.4%) and assets (-38.1%) demonstrate fundamental business failure and capital destruction
- Long-term debt of $4.1M creates refinancing pressure as cash reserves deplete
- Negative interest coverage of -2036x indicates inability to service debt from operations
Key Metrics to Watch
- Revenue generation and return to positive sales figures
- Monthly cash burn rate and timeline to cash depletion
- Operating cash flow stabilization and path to breakeven
- Debt restructuring or refinancing activities
- Management changes or strategic pivots in SEC filings
Financial Metrics
Revenue
0.0
Net Income
-2.0M
EPS (Diluted)
$-0.03
Free Cash Flow
-1.4M
Total Assets
5.3M
Cash
4.0M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-40.4%
ROA
-38.1%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
15.83x
Quick Ratio
15.83x
Debt/Equity
0.82x
Debt/Assets
5.5%
Interest Coverage
-2,036.00x
Long-term Debt
4.1M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-24T04:00:11.242491 |
Data as of: 2025-09-30 |
Powered by Claude AI